107 related articles for article (PubMed ID: 23850623)
1. A THz spectroscopy method for quantifying the degree of crystallinity in freeze-dried gelatin/amino acid mixtures: an application for the development of rapidly disintegrating tablets.
Darkwah J; Smith G; Ermolina I; Mueller-Holtz M
Int J Pharm; 2013 Oct; 455(1-2):357-64. PubMed ID: 23850623
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of crystalline-amorphous blends of sucrose with terahertz-pulsed spectroscopy: the development of a prediction technique for estimating the degree of crystallinity with partial least squares regression.
Ermolina I; Darkwah J; Smith G
AAPS PharmSciTech; 2014 Apr; 15(2):253-60. PubMed ID: 24306674
[TBL] [Abstract][Full Text] [Related]
3. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
4. Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents.
AlHusban F; Perrie Y; Mohammed AR
Eur J Pharm Biopharm; 2010 Jun; 75(2):254-62. PubMed ID: 20332027
[TBL] [Abstract][Full Text] [Related]
5. Application of Texture Analysis Technique in Formulation Development of Lyophilized Orally Disintegrating Tablets Containing Mannitol, Polyvinylpyrrolidone and Amino Acids.
Hackl E; Ermolina I
AAPS PharmSciTech; 2019 Jan; 20(2):71. PubMed ID: 30631978
[TBL] [Abstract][Full Text] [Related]
6. Preparation, optimisation and characterisation of lyophilised rapid disintegrating tablets based on gelatin and saccharide.
AlHusban F; Perrie Y; Mohammed AR
Curr Drug Deliv; 2010 Jan; 7(1):65-75. PubMed ID: 19863486
[TBL] [Abstract][Full Text] [Related]
7. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
[TBL] [Abstract][Full Text] [Related]
8. Application of freeze-drying technology in manufacturing orally disintegrating films.
Liew KB; Odeniyi MA; Peh KK
Pharm Dev Technol; 2016; 21(3):346-53. PubMed ID: 25597618
[TBL] [Abstract][Full Text] [Related]
9. Terahertz-spectroscopy for non-destructive determination of crystallinity of L-tartaric acid in smartFilms® and tablets made from paper.
Ornik J; Knoth D; Koch M; Keck CM
Int J Pharm; 2020 May; 581():119253. PubMed ID: 32217156
[TBL] [Abstract][Full Text] [Related]
10. Using terahertz pulsed spectroscopy to quantify pharmaceutical polymorphism and crystallinity.
Strachan CJ; Taday PF; Newnham DA; Gordon KC; Zeitler JA; Pepper M; Rades T
J Pharm Sci; 2005 Apr; 94(4):837-46. PubMed ID: 15736195
[TBL] [Abstract][Full Text] [Related]
11. In situ lyophilisation of nifedipine directly in hard gelatine capsules.
Crum M; Elkordy AA; Zarara M; Elkordy EA
Pharm Dev Technol; 2013; 18(6):1379-90. PubMed ID: 22992055
[TBL] [Abstract][Full Text] [Related]
12. Effect of co-solutes and process variables on crystallinity and the crystal form of freeze-dried myo-inositol.
Izutsu KI; Kusano R; Arai R; Yoshida H; Ito M; Shibata H; Sugano K; Goda Y; Terada K
Int J Pharm; 2016 Jul; 509(1-2):368-374. PubMed ID: 27282535
[TBL] [Abstract][Full Text] [Related]
13. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets.
Alhusban F; Perrie Y; Mohammed AR
Eur J Pharm Biopharm; 2011 Nov; 79(3):627-34. PubMed ID: 21693189
[TBL] [Abstract][Full Text] [Related]
14. Influence of spray-drying, freeze-drying and vacuum-drying on physicochemical and functional properties of gelatin from Labeo rohita swim bladder.
Kanwate BW; Ballari RV; Kudre TG
Int J Biol Macromol; 2019 Jan; 121():135-141. PubMed ID: 30290261
[TBL] [Abstract][Full Text] [Related]
15. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
16. Development and optimization of lyophilized orally disintegrating tablets using factorial design.
Ahmed IS; Shamma RN; Shoukri RA
Pharm Dev Technol; 2013; 18(4):935-43. PubMed ID: 22107175
[TBL] [Abstract][Full Text] [Related]
17. Strategies and formulations of freeze-dried tablets for controlled drug delivery.
Tran PHL; Lee BJ; Tran TTD
Int J Pharm; 2021 Mar; 597():120373. PubMed ID: 33577912
[TBL] [Abstract][Full Text] [Related]
18. Freeze drying: exploring potential in development of orodispersible tablets of sumatriptan succinate.
Gugulothu D; Desai P; Pandharipande P; Patravale V
Drug Dev Ind Pharm; 2015 Mar; 41(3):398-405. PubMed ID: 24384027
[TBL] [Abstract][Full Text] [Related]
19. Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles.
Zillies JC; Zwiorek K; Hoffmann F; Vollmar A; Anchordoquy TJ; Winter G; Coester C
Eur J Pharm Biopharm; 2008 Oct; 70(2):514-21. PubMed ID: 18582569
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]